A practical reference on c-Met receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-06 and is reviewed periodically as new material appears.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical lyophilized research form. |
| Solubility | Soluble in DMSO; limited in water | Depends on purity and salt form. |
| Storage temperature | -20 °C or lower | Desiccated and protected from light. |
| Analytical method | RP-HPLC and LC-MS | Common for purity and identity. |
| Regulatory status | Research chemical in many countries | Not widely approved as a medicine. |
Dihexa is not approved as a medicine in major regulatory jurisdictions. It is commonly sold as a research chemical for laboratory use, though such products may not be standardized or independently verified. Scientific literature on dihexa includes in vitro assays, rodent studies, and reviews that discuss its proposed mechanism. The distinction between peer-reviewed findings and commercial promotion is important when evaluating available information. Open questions include its precise binding interactions, pharmacokinetics, and whether animal results translate to human biology.
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
== Interactions == Concomitant or recent (previous 14 days) monoamine oxidase inhibitor (MAOI) use can lead to hypertensive reactions, including hypertensive crisis, and should be avoided. Clinical studies have found minimal or no influence of certain MAOIs like the weak non-selective MAOI linezolid and the potent selective MAO-B inhibitor selegiline (as a transdermal patch) on the pharmacokinetics of pseudoephedrine. This is in accordance with the fact that pseudoephedrine is not metabolized by monoamine oxidase (MAO). However, pseudoephedrine induces the release of norepinephrine, which MAOIs inhibit the metabolism of, and as such, MAOIs can still potentiate the effects of pseudoephedrine. No significant pharmacodynamic interactions have been found with selegiline, but linezolid potentiated blood pressure increases with pseudoephedrine. However, this was deemed to be without clinical significance in the case of linezolid, though it was noted that some individuals may be more sensitive to the sympathomimetic effects of pseudoephedrine and related agents. Pseudoephedrine is contraindicated with MAOIs like phenelzine, tranylcypromine, isocarboxazid, and moclobemide due to the potential for synergistic sympathomimetic effects and hypertensive crisis. It is also considered to be contraindicated with linezolid and selegiline as some individuals may react more sensitively to coadministration.
"Alsos Digital Library for Nuclear Issues – Plutonium". Washington and Lee University. Archived from the original on February 3, 2009. Retrieved February 15, 2009. Sutcliffe, W. G.; et al. (1995). "A Perspective on the Dangers of Plutonium". Lawrence Livermore National Laboratory. Archived from the original on September 29, 2006. "Physical, Nuclear, and Chemical, Properties of Plutonium". IEER. 2005. Retrieved February 15, 2009. "A History of Plutonium". Los Alamos National Laboratory. Retrieved July 8, 2023. Bhadeshia, H. "Plutonium crystallography". Samuels, D. (2005). "End of the Plutonium Age". Discover Magazine. 26 (11). Pike, J.; Sherman, R. (2000). "Plutonium production". Federation of American Scientists. Archived from the original on February 3, 2009. Retrieved February 15, 2009. "Plutonium Manufacture and Fabrication". Ong, C. (1999). "World Plutonium Inventories". Nuclear Files.org. Archived from the original on August 5, 2014. Retrieved February 15, 2009. "Challenges in Plutonium Science". Los Alamos Science. I & II (26). 2000. Retrieved February 15, 2009. "Plutonium". Royal Society of Chemistry. Retrieved February 6, 2015. "Plutonium". The Periodic Table of Videos. University of Nottingham. Retrieved February 6, 2015. Plutonium Fuel Fabrication by Argonne National Laboratory on YouTube
=== Antibiotic stewardship === Procalcitonin guided cessation of antibiotic use reduces duration of antibiotic exposure and lowers mortality in critically ill patients in the Intensive Care Unit. In adult emergency department patients with respiratory tract illnesses, PCT-guided treatment groups had reduced antibiotic use. PCT references ranges are also used to determine the likelihood a patient has systemic infection (sepsis), thereby reducing incidence of unnecessary antibiotic use in cases where sepsis is unlikely. Although some literature differs in antibiotic cessation requirements the general consensus is stopping antibiotics when procalcitonin levels fall 80% below peak or below 0.5 μg/L at day five or later during antibiotic therapy.
In her reply, Meitner concurred. "At the moment, the interpretation of such a thoroughgoing breakup seems very difficult to me, but in nuclear physics we have experienced so many surprises, that one cannot unconditionally say: 'it is impossible'." On 22 December 1938, Hahn sent a manuscript to Naturwissenschaften reporting their radiochemical results, which were published on 6 January 1939. On 27 December, Hahn telephoned the editor of the Naturwissenschaften and requested an addition to the article, speculating that some platinum group elements previously observed in irradiated uranium, which were originally interpreted as transuranium elements, could in fact be technetium (then called "masurium"), mistakenly believing that the atomic masses had to add up rather than the atomic numbers. By January 1939, he was sufficiently convinced of the formation of light elements that he published a new revision of the article, retracting former claims of observing transuranic elements and neighbours of uranium. As a chemist, Hahn was reluctant to propose a revolutionary discovery in physics, but Meitner and Frisch worked out a theoretical interpretation of nuclear fission, a term appropriated by Frisch from biology. In January and February they published two articles discussing and experimentally confirming their theory.
Sources: en.wikipedia.org
==== Matrix assisted laser desorption electrospray ionization ==== Another method good for biomolecules is matrix assisted laser desorption electrospray ionization (MALDESI). In this technique, it utilizes Infrared laser ionization to excite the sample molecules to allow for the desorbed ions to be ready for MS analysis. The geometry of the source and the distance between the ESI and matrix will have and effect on the efficiency of the sample compound. This technique can also be used with aqueous samples as well. The water droplet can be placed at the focal point of the laser, or the droplet can be dried to form the solid. Planar samples do not need sample preparation to perform this experiment.
Amitay (1958), lobbyist, former executive director of the American Israel Public Affairs Committee and vice chairman of the Jewish Institute for National Security Affairs Richard Grossman (1965), critic and organizer against corporate power, former director of Greenpeace USA Brian Flanagan (1968), former member of the Students for a Democratic Society and Weather Underground David Gilbert (1966), leader of Students for a Democratic Society and participant in the deadly 1981 Brink's robbery with Kathy Boudin, the mother of his child Chesa Boudin Ted Gold* (1968), student activist, leader of the Students for a Democratic Society and member of the Weatherman group who died in the 1970 Greenwich Village townhouse explosion John Jacobs (1969), student activist, member of Students for a Democratic Society and the Weather Underground, went into hiding after the fatal 1970 Greenwich Village townhouse explosion Mark Rudd (1969), president of Students for a Democratic Society and member of the Weather Underground Stephen Donaldson (1970), bisexual political activist, founder of the Student Homophile League at Columbia, the oldest college LGBTQ organization in the world David Kaczynski (1970), anti-death penalty activist, brother of Unabomber Theodore Kaczynski Robert Roth* (1970), activist associated with the Students for a Democratic Society Sheena Wright (1990), CEO of the United Way of New York City David Kaiser (1991), philanthropist, environmental activist, president of the Rockefeller Family Fund, great-great-grandson of John D.
If compelling archaeological reasons for supposing that the ages come from exactly contemporary samples do not exist, then results must be regarded as suspect. If there exists no prior reason to believe that two samples are truly of the same age, and even if their ages are statistically indistinguishable, they are as likely to be as far apart in true age as the measured difference between them as they are to be of the same age. Charcoal was seen historically as an ideal medium for carbon dating. When long-lived tree species, such as oak and juniper, are used, however, there is a particular danger of encountering the "old wood" problem. For example, the date being measured may be from heartwood, which is already many centuries old by the time the tree was felled. Another difficulty is that of a possible time-lag between felling and final deposition. The timber may have had an extensive history of use and re-use. A method of ameliorating this problem is to date young growth, if available, for example hazel twigs. Dating of artefacts using accelerator mass spectrometry is the gold standard dating method of today; charcoal-sourced dates are seen as unreliable. In establishing the chronology of a site, a representative spread of dates is required before interpretation can be attempted.
==== Mechanism of action ==== Dronabinol partially stimulates both the cannabinoid receptor 1 (CBR1) and cannabinoid receptor 2 (CBR2), with a stronger stimulatory effect observed in the former. Dronabinol prevents nausea and vomiting and stimulates appetite by directly acting on the CB1 receptors in the vomiting and appetite control centres in the brain.
== Education and career == Bhatt graduated Boston Latin School, earned his science degree as a National Merit Scholar from MIT, an MD from Cornell and an MPH from Harvard. He received his Executive MBA from the University of Oxford in 2024. He trained in internal medicine and cardiology at the University of Pennsylvania and Cleveland Clinic, completing fellowships in interventional cardiology and cerebral and peripheral vascular intervention. He served as chief interventional fellow at Cleveland Clinic where he worked as an interventional cardiologist, associate professor of medicine, director of the interventional cardiology fellowship, associate director of the cardiovascular medicine fellowship, and associate director of the cardiovascular coordinating center. Later, he became the Chief of Cardiology at the VA Boston Healthcare System and, subsequently, the Interventional Cardiovascular Programs executive director at Brigham and Women's Hospital. Additionally, he was a Senior Investigator in the TIMI Study Group and Editor-in-Chief of the Harvard Heart Letter. In 2012, he was appointed a professor of medicine at Harvard Medical School.
Sources: en.wikipedia.org
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.
Mass spectrometry is commonly used to confirm molecular mass, while RP-HPLC estimates purity. These methods can be combined with amino acid analysis or NMR for further structural confirmation. A certificate of analysis alone does not guarantee independent verification.
Legality depends on the country and the intended use. In many places it is not approved as a drug and may be regulated as a research chemical. Buyers should check local laws and institutional policies before obtaining it.
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.